Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

EPA/IVA stock hub

EPA/IVA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

EPA/IVAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

945.1M

Euronext Paris

Market data

Live price

Current market quote for this ticker.

Current price

EPA/IVA

In the news

Latest news · EPA/IVA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-60

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All EPA/IVA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

169

Groups with data

Currency

EUR

Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	FR
Employees	77
Employees Change	-41%
Employees Change Percent	-34.75
Enterprise value	EUR 1.1B
Exchange	Euronext Paris
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	FR0013233012
Last refreshed	2026-05-10
Market cap	EUR 945.1M
Price	EUR 4.55
Price currency	EUR
Rev Per Employee	92,616.44x
Sector	Healthcare
Sic	2836
Symbol	epa/IVA
Website	https://inventivapharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-37.47%
EV Earnings	-3.04x
EV/FCF	-10.24x
EV/Sales	159.17x
FCF yield	-11.12%
P/B ratio	-33.13x
P/S ratio	139.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	99.67%
Gross Profit	EUR 6.7M
Gross Profit Growth	-58.28%
Gross Profit Growth Q	-90.1%
Gross Profit Growth3 Y	-27.72%
Gross Profit Growth5 Y	-20.42%
Net Income	EUR -354.1M
Net Income Growth Years	0%
Pretax Margin	-5,237.63%
Profit Per Employee	EUR -4.9M
ROA	-45.08
Roa5y	-46.67
ROCE	-77.2
ROIC	-59.97

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	41.34%
Cagr3y	23.76%
Cagr5y	-17.55%
EPS Growth Quarters	1
EPS Growth Years	1
Revenue Growth	-52.03x
Revenue Growth Q	-89.87x
Revenue Growth Years	0x
Revenue Growth3 Y	-29.05x
Revenue Growth5 Y	-21.05x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.04
Assets	EUR 249.5M
Cash	EUR 99.8M
Current Assets	EUR 244.5M
Current Liabilities	EUR 77.4M
Debt	EUR 230.9M
Debt FCF	EUR -2.2
Equity	EUR -28.5M
Interest Coverage	-3.96
Liabilities	EUR 278M
Long Term Assets	EUR 5M
Long Term Liabilities	EUR 200.7M
Net Cash	EUR -131.1M
Net Cash By Market Cap	EUR -13.87
Tangible Book Value	EUR -28.7M
Tangible Book Value Per Share	EUR -0.15
WACC	9.57

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.16
Net Working Capital	EUR 99.6M
Quick ratio	1.41
Working Capital	EUR 167.1M
Working Capital Turnover	EUR 0.09

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-212.49%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	41.3%
200-day SMA	4.34
3Y total return	89.58%
50-day SMA	4.88
50-day SMA vs 200-day SMA	50over200
5Y total return	-61.89%
All Time High	16.3
All Time High Change	-72.09%
All Time High Date	2021-01-21
All Time Low	1.43
All Time Low Change	217.29%
All Time Low Date	2024-10-08
ATR	0.25
Beta	0.88
Beta1y	0.64
Beta2y	0.72
Ch YTD	15.34
High	4.6
High52	6.2
High52 Date	2026-01-23
High52ch	-26.61%
Low	4.46
Low52	2.56
Low52 Date	2025-07-02
Low52ch	77.73%
Ma50ch	-6.76%
Price vs 200-day SMA	4.81%
RSI	48.19
RSI Monthly	54.28
RSI Weekly	49.92
Sharpe ratio	0.81x
Sortino ratio	1.39
Total Return	-212.49%
Tr YTD	15.34
Tr1w	4.84%
Tr3m	-9.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -132.9M
Operating margin	-1,965.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	122,208,545%
Net Borrowing	-5,980,000
Shares Insiders	4.76%
Shares Institutions	51.27%
Shares Out	207,707,475
Shares Qo Q	143.26%
Shares Yo Y	212.49%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -131.9M
Average Volume	231,965.4x
Bv Per Share	-0.15
CAPEX	EUR -247,000
Ch1w	4.84
Ch1y	41.3
Ch3m	-9.36
Ch3y	89.58
Ch5y	-61.89
Ch6m	28.17
Change	1%
Change From Open	-1.09
Close	4.51
Days Gap	2.11
Depreciation Amortization	388,000
Dollar Volume	726,339.3
Earnings Date	2026-09-25
EBIT	EUR -132.9M
EBITDA	EUR -132.5M
EPS	EUR -1.9
F Score	3
FCF	EUR -105.1M
FCF EV Yield	-9.77x
FCF Per Share	EUR -0.51
Financing CF	241,286,000
Fiscal Year End	December
Founded	2,011
Income Tax	EUR 22,000
Investing CF	-133,186,000
Is Primary Listing	1
Last Earnings Date	2026-03-30
Last Report Date	2025-12-31
Ma150	4.45
Ma150ch	2.32%
Ma20	4.5
Ma20ch	1.02%
Net CF	2,748,000
Next Earnings Date	2026-09-25
Open	4.6
Position In Range	64.29
Ppne	2,979,000
Price Date	2026-05-08
Relative Volume	0.68x
Revenue	6,761,000x
SBC By Revenue	395.93x
Share Based Comp	26,769,000
Tax By Revenue	0.33x
Tr6m	28.17%
Volume	159,635
Z Score	-1.98

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does EPA/IVA pay a dividend?

Capital-return profile for this ticker.

Performance

EPA/IVA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns EPA/IVA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+51.3%

Share of float held by funds and institutions

Insider ownership

+4.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+212.5%

Negative means the company is buying back shares.

Technical

EPA/IVA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.2

Neutral momentum band

Price vs 200-day MA

+4.8%

50/200-day relationship not available

Beta (5Y)

0.88

Moves roughly with the market

Sharpe ratio

0.81

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About EPA/IVA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current epa/IVA stock rating?

epa/IVA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full epa/IVA analysis?

The full report lives at /stocks/epa/IVA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for epa/IVA?

The latest report frames epa/IVA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the epa/IVA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.